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Letters to the EditorsThe association between tumor-infiltrating
lymphocytes (TILs) and metastatic course in
neuroendocrine neoplasmsTo the Editors:
We have read with interest the article by Crippa and
colleagues1 concerning the long-term outcomes and
prognostic factors in neuroendocrine carcinomas of
the pancreas, with particular emphasis on their
morphology. Here, we report some of our histologic
research on gastroenteropancreatic and lung neuroen-
docrine neoplasms, focused on tumor-infiltrating lym-
phocytes (TILs). We studied 25 surgical specimens (4
pancreas, 9 lung, 12 midgut) of well-differentiated
(G1) neuroendocrine carcinoid tumors, according to
the World Health Organization criteria,1,2 all with a
diameter >2 cm,3 and confirmed by immunohistochem-
istry for chromogranin A, synaptophysin, and neuron-
specific enolase.3
The following subtypes of lymphocytes were investi-
gated: CD4 + T-helper, CD8 + T-cytotoxic, CD20+ B, and
CD56+ Nk. Only the lymphocytes located within the
tumor and not those in organized lymphatic centers
have been considered TILs. We have categorized their
presence as absent, mild, and moderate.3,4
A moderate lymphocytic infiltration was found in
about 25% of these well-differentiated neoplasms, all of
which had no distant metastases to liver or pulmonary
hilar lymph nodes during a follow-up period >10 years;
mild or absent lymphocytic infiltrates have been
observed in those cases with metastatic spread, discov-
ered synchronously or after follow-up of 10 years
(P < .05). Our findings led us to support that a moderate
lymphocytic infiltrate represents the local expression of
an immunologic response to neoplastic cells, opposing
their metastatic spread. Conversely, the absence of any
substantial TILs may be a sign of an immunotolerance,
likely secondary to tissue compatibility between host
and neoplasia, or a local immunosuppressive action by
tumor-specific molecular mechanisms. Both of these
conditions can favor invasion of blood vessels or lym-
phatics and subsequent metastases.
Similarly, we have observed the absence of a similar
lymphocytic immune response in small-cell lung cancers,
which are histogenetically correlated with neuroendo-
crine carcinomas and have a great metastatic potential.5
The immunoscore should also be considered a
further prognostic indicator,6 able to identify those
neuroendocrine neoplasms prone to metastasis and
should also be taken into consideration among the
morphology of pancreatic neuroendocrine carcinomas.
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Commentary on: Post-thyroidectomyhypocalcemia is related to parathyroid
dysfunction even in patients with normal
parathyroid hormone concentrations early
after surgeryTo the Editors:
We read with interest the article “Post-thyroidectomy
hypocalcemia is related to parathyroid dysfunction even
in patients with normal parathyroid hormone concen-
trations early after surgery” by Raffaelli et al.1 We
congratulate the authors for researching a very impor-
tant postsurgical complication after total thyroidectomy.
After a thorough reading of the article, we have a few
comments and questions.
Recently many authors have investigated the use of
postoperative parathyroid hormone (PTH) estimation
to predict postoperative hypocalcemia. Wiseman et al2
developed an algorithm using postoperative parathy-
roid hormone levels (<10, 10–15, and >15 pg/mL) to
reduce hypocalcemic complications of thyroidec-
tomy.2,3 In the present study by Raffaelli et al, 211/
1,171 (18%) patients with euparathyroid (PTH >10SURGERY 1709
